IRIS
CICERI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.190
EU - Europa 26.053
AS - Asia 24.423
SA - Sud America 6.100
Continente sconosciuto - Info sul continente non disponibili 1.718
AF - Africa 530
OC - Oceania 62
AN - Antartide 1
Totale 85.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.437
RU - Federazione Russa 13.244
SG - Singapore 9.236
CN - Cina 6.884
IT - Italia 5.591
BR - Brasile 4.933
HK - Hong Kong 2.969
VN - Vietnam 2.301
SE - Svezia 2.297
FR - Francia 1.187
BD - Bangladesh 935
DE - Germania 883
CA - Canada 822
GB - Regno Unito 696
IN - India 494
AR - Argentina 439
NL - Olanda 348
FI - Finlandia 330
RO - Romania 307
MX - Messico 273
AT - Austria 255
JP - Giappone 230
EC - Ecuador 213
ID - Indonesia 206
ZA - Sudafrica 193
TR - Turchia 185
PL - Polonia 182
ES - Italia 177
IQ - Iraq 166
IE - Irlanda 151
CO - Colombia 137
JM - Giamaica 124
CR - Costa Rica 115
PY - Paraguay 101
PK - Pakistan 95
VE - Venezuela 87
CL - Cile 79
UA - Ucraina 77
SA - Arabia Saudita 75
MY - Malesia 73
LT - Lituania 67
MA - Marocco 67
TT - Trinidad e Tobago 62
UZ - Uzbekistan 62
HN - Honduras 60
AE - Emirati Arabi Uniti 58
EG - Egitto 58
PH - Filippine 57
SV - El Salvador 52
AU - Australia 51
DZ - Algeria 49
TN - Tunisia 48
NI - Nicaragua 46
UY - Uruguay 46
GT - Guatemala 45
NP - Nepal 42
PE - Perù 41
IL - Israele 37
IR - Iran 35
BE - Belgio 34
KR - Corea 34
KE - Kenya 32
JO - Giordania 31
PR - Porto Rico 30
AZ - Azerbaigian 27
DO - Repubblica Dominicana 27
KZ - Kazakistan 25
CH - Svizzera 24
TH - Thailandia 23
LB - Libano 21
AL - Albania 20
CZ - Repubblica Ceca 19
CW - ???statistics.table.value.countryCode.CW??? 18
TW - Taiwan 18
BB - Barbados 17
EE - Estonia 17
ET - Etiopia 17
PT - Portogallo 17
BO - Bolivia 16
BY - Bielorussia 16
MD - Moldavia 16
PA - Panama 15
DK - Danimarca 13
GP - Guadalupe 13
BG - Bulgaria 12
PS - Palestinian Territory 12
SY - Repubblica araba siriana 12
BS - Bahamas 11
GR - Grecia 11
OM - Oman 11
BA - Bosnia-Erzegovina 10
BH - Bahrain 9
CI - Costa d'Avorio 9
HR - Croazia 9
KW - Kuwait 9
NG - Nigeria 9
AM - Armenia 8
AO - Angola 8
HU - Ungheria 8
NZ - Nuova Zelanda 8
Totale 83.206
Salva come PNG Salva come JPEG
Città #
Singapore 4.120
Ashburn 3.706
Hong Kong 2.922
Moscow 2.899
San Jose 2.874
Dallas 2.107
Milan 1.524
Shanghai 1.345
Council Bluffs 1.271
Hefei 1.099
Lauterbourg 948
New York 858
Beijing 853
Princeton 824
Ho Chi Minh City 814
Lawrence 812
Santa Clara 637
Los Angeles 533
Hanoi 492
Phoenix 478
São Paulo 468
Rome 388
Nuremberg 252
Boardman 236
Miano 201
Brooklyn 179
Orem 178
Montreal 176
Munich 176
Atlanta 164
Helsinki 163
Chicago 159
Rio de Janeiro 157
London 156
Tokyo 153
Warsaw 151
Denver 148
Naples 146
Washington 141
Dublin 137
Toronto 136
North Bergen 135
Chennai 123
Guangzhou 122
Boston 120
Vienna 120
Seattle 117
Belo Horizonte 110
Da Nang 110
Johannesburg 108
Brescia 106
Stockholm 104
Manchester 103
Bologna 101
Mexico City 101
Haiphong 98
Buffalo 96
Cesano Boscone 96
Houston 94
Poplar 93
Frankfurt am Main 92
Lappeenranta 88
Brasília 87
San José 85
Turin 84
Curitiba 83
Amsterdam 81
Guayaquil 80
Ankara 78
Kingston 77
Philadelphia 77
The Dalles 75
Quito 74
Florence 71
Turku 71
Campinas 69
Pune 69
Baghdad 62
San Francisco 62
Castelseprio 61
Columbus 61
Porto Alegre 61
Hangzhou 57
Salvador 57
Tashkent 56
Tianjin 56
Genoa 55
Biên Hòa 53
Hải Dương 53
Miami 53
Mumbai 52
Las Vegas 49
Palermo 49
Dhaka 48
Shenzhen 47
San Salvador 44
Calgary 43
Goiânia 42
Guarulhos 42
Managua 42
Totale 39.784
Salva come PNG Salva come JPEG
Nome #
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 456
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 398
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations 279
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 264
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 239
Loss of mismatched HLA in leukemia after stem-cell transplantation 238
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 225
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 222
Use of HSV-TK transduced donor lymphocytes in the context of allogeneic bone marrow transplantation: A paradigm of current applications and limitations in gene therapy 218
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 217
Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL) 213
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 198
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 197
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 195
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 195
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 192
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 192
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 192
Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation 190
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 186
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 185
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 185
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 185
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 185
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 175
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 175
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease 173
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 171
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 170
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 169
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 166
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 164
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 164
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 163
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 161
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 161
Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy 160
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 160
Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients 159
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 158
Biobanking for COVID-19 research 157
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 156
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 156
Long-term lineage commitment in haematopoietic stem cell gene therapy 155
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 155
Impact of Hydroxyurea to Treat Haematological Disorders on Male Fertility: Two Case Reports and a Systematic Review 154
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 153
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 153
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 151
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 150
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 150
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation 149
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 149
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 149
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus 148
CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature 148
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 148
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 147
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia 145
A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation 143
One-year mental health outcomes in a cohort of COVID-19 survivors 143
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 143
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 141
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 141
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 141
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 141
Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population 140
A T cell epitope encoded by a subset HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation 140
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 139
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 139
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study 139
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 138
QTc interval prolongation, inflammation, and mortality in patients with COVID-19 138
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 137
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 137
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 136
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 136
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 136
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 135
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 135
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 135
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 134
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study 134
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy 134
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 132
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 132
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 131
No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection 131
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients 131
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients 130
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party 130
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 130
Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases 130
Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft-versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases 130
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 129
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 128
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 128
Testosterone in males with COVID-19: A twelve-month cohort study 128
T cells for suicide gene therapy: Activation, functionality and clinical relevance 128
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 128
Totale 16.499
Salva come PNG Salva come JPEG
Categoria #
all - tutte 507.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 507.711
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022730 0 0 0 240 55 36 65 102 57 90 27 58
2022/20234.925 1.762 862 248 92 190 567 209 334 392 76 113 80
2023/20243.456 201 226 396 356 327 626 192 273 29 137 179 514
2024/202515.337 1.666 466 332 471 479 1.263 2.157 1.450 2.454 2.073 1.176 1.350
2025/202646.296 3.275 3.470 3.226 6.716 3.357 1.293 4.345 3.161 11.765 2.324 1.669 1.695
2026/202713.783 1.878 3.535 2.881 5.489 0 0 0 0 0 0 0 0
Totale 85.077